A Comparison of Chemotherapy Used with and without Apatinib for Patients with Ovarian Carcinoma Who Progressed after Standard Regimens: A Systematic Review and Meta-Analysis

<div>Objective response rate of chemotherapy plus apatinib in comparison with chemotherapy alone in the patients with ovarian carcinoma.</div>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: A Comparison of Chemotherapy Used with and without Apatinib for Patients with Ovarian Carcinoma Who Progressed after Standard Regimens: A Systematic Review and Meta-Analysis 

Figure 3 | A Comparison of Chemotherapy Used with and without Apatinib for Patients with Ovarian Carcinoma Who Progressed after Standard Regimens: A Systematic Review and Meta-Analysis 